Topic: Us Parkinson
NEW YORK (Reuters Health) - People with Parkinson's disease face an increased risk of the most deadly type of skin cancer, new research confirms.Exams of more than 2,000 people with Parkinson's disease found that about 1 percent currently had ...
SANN), a Swiss specialty pharmaceutical company focused on neuromuscular diseases, announced today positive data from its Phase IIb study (FJORD). The key finding of the trial is that JP-1730/ fipamezole reduces levodopa-induced dyskinesia in Parkinson's patients. The FJORD study was a ...
